Londhe Sanjay Bhalchandra, Patwardhan Meghana, Shah Ravi Vinod, Oak Mugdha, Shah Asit, Antao Nicholas, Khot Rahul
Holy Spirit Hospital, Mumbai, India.
Criticare Superspeciality Hospital, Andheri, Mumbai, India.
Indian J Orthop. 2022 Jun 25;56(8):1363-1369. doi: 10.1007/s43465-022-00668-7. eCollection 2022 Aug.
One of the most common fractures in the elderly population is a fracture of the neck of femur. Effective post-operative analgesia is a major challenge. Age-related co-morbidities restrict the choice of analgesics. The purpose of this study was to compare the efficacy and safety of transdermal buprenorphine [TDB] patch and conventional analgesics following hemiarthroplasty for intra-capsular fracture neck of femur.
This was a prospective, randomized control study done in 60 patients undergoing hemiarthroplasty for intra-capsular fracture neck of femur over a period of 2 years. Patients were randomized in 2 groups. Group A received a combination of IV paracetamol and tramadol for first 48 h followed by oral formulation. In Group B patients, a transdermal buprenorphine patch of 5 mcg/h was applied at the beginning of surgery and was continued 2 weeks post-operative.Pain score by VAS was observed both at rest and on movement and followed up till 14 days post-operative. Primary target was to maintain a VAS ≤ 4. Rescue analgesic was given if the VAS was ≥ 6. Secondary targets were number of rescue analgesics required, adverse reactions and complications if any.
Group B had significantly lower pain scores at rest and during movement [ value 0.0012 to ≤ 0.0001], so was rescue analgesia requirement. No significant side effects were seen in TDB group.
TDB patch is safe and provides superior analgesia and compliance as compared to conventional analgesics in the post-operative period in proximal femur fracture surgeries.
老年人群中最常见的骨折之一是股骨颈骨折。有效的术后镇痛是一项重大挑战。与年龄相关的合并症限制了镇痛药的选择。本研究的目的是比较透皮丁丙诺啡[TDB]贴剂与传统镇痛药在股骨颈囊内骨折半髋关节置换术后的疗效和安全性。
这是一项前瞻性随机对照研究,在2年时间里对60例行股骨颈囊内骨折半髋关节置换术的患者进行。患者被随机分为2组。A组在最初48小时接受静脉注射扑热息痛和曲马多的联合治疗,随后改为口服制剂。B组患者在手术开始时应用5微克/小时的透皮丁丙诺啡贴剂,并持续至术后2周。在休息和活动时均观察视觉模拟评分(VAS)疼痛评分,并随访至术后14天。主要目标是维持VAS≤4。如果VAS≥6,则给予解救镇痛药。次要目标是所需解救镇痛药的数量、不良反应和并发症(如有)。
B组在休息和活动时的疼痛评分显著更低[值为0.0012至≤0.0001],解救镇痛需求也是如此。TDB组未见明显副作用。
在股骨近端骨折手术的术后阶段,与传统镇痛药相比,TDB贴剂安全且提供更好的镇痛效果和依从性。